Variable | Controlled (n = 108) | Uncontrolled (n = 156) | P-value |
---|---|---|---|
Age (yr) | 0.005 | ||
20–40 | 3 (15.79) | 16 (84.21) | |
41–60 | 49 (36.30) | 86 (63.70) | |
>60 | 56 (50.91) | 54 (49.09) | |
Sex | 0.302 | ||
Female | 84 (76.36) | 110 (23.64) | |
Male | 24 (34.28) | 46 (65.72) | |
Comorbidity | 0.612 | ||
No | 62 (40.26) | 92 (59.74) | |
Yes | 46 (41.82) | 64 (58.18) | |
Type of therapy (antihypertension drug) | |||
Monotherapy | 101 (41.74) | 141 (58.26) | 0.365 |
Combination | 7 (30.43) | 16 (69.57) | |
Education level | 0.099 | ||
Elementary school | 26 (36.62) | 47 (64.38) | |
Middle school | 22 (59.46.) | 15 (40.54) | |
High school | 37 (38.95) | 58 (61.05) | |
College | 23 (38.99) | 36 (61.02) | |
Medication adherence (pill count) | |||
≥80% | 98 (47.80) | 107 (52.20) | 0.000 |
<80% | 10 (16.95) | 49 (83.05) |